KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomarin Pharmaceutical (BMRN) Exchange Rate Effect: 2014-2025

Historic Exchange Rate Effect for Biomarin Pharmaceutical (BMRN) over the last 12 years, with Sep 2025 value amounting to $739,000.

  • Biomarin Pharmaceutical's Exchange Rate Effect rose 125.47% to $739,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.2 million, marking a year-over-year increase of 6.43%. This contributed to the annual value of $4.8 million for FY2024, which is 269.27% up from last year.
  • According to the latest figures from Q3 2025, Biomarin Pharmaceutical's Exchange Rate Effect is $739,000, which was up 124.13% from -$3.1 million recorded in Q2 2025.
  • In the past 5 years, Biomarin Pharmaceutical's Exchange Rate Effect registered a high of $3.3 million during Q2 2024, and its lowest value of -$3.6 million during Q4 2023.
  • In the last 3 years, Biomarin Pharmaceutical's Exchange Rate Effect had a median value of $739,000 in 2025 and averaged $218,000.
  • Over the last 5 years, Biomarin Pharmaceutical's Exchange Rate Effect had its largest YoY gain of 814.81% in 2023, and its largest YoY loss of 5,236.62% in 2023.
  • Quarterly analysis of 5 years shows Biomarin Pharmaceutical's Exchange Rate Effect stood at -$22,000 in 2021, then spiked by 422.73% to $71,000 in 2022, then slumped by 5,236.62% to -$3.6 million in 2023, then soared by 168.66% to $2.5 million in 2024, then surged by 125.47% to $739,000 in 2025.
  • Its last three reported values are $739,000 in Q3 2025, -$3.1 million for Q2 2025, and -$1.4 million during Q1 2025.